ask="N/A"
ask_size="N/A"
average_daily_volume="608605"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.15"
change_from_200_day_moving_average="4.24"
change_from_50_day_moving_average="-5.83"
change_from_52_week_high="-39.75"
change_From_52_week_low="23.79"
change_in_percent="+0.21%"
close="70.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.66"
eps_estimate_next_year="-6.66"
ex_dividend_date="N/A"
float_shares="37661000"
high="71.16"
high_52_weeks="110.06"
last_trade_date="12/30/2016"
last_trade_price="70.31"
last_trade_size="26486"
last_trade_time="4:00pm"
low="69.66"
low_52_weeks="46.52"
market_capitalization="2.87B"
moving_average_200_day="66.07"
moving_average_50_day="76.14"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.67"
open="70.28"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+6.42%"
percent_change_from_50_day_moving_average="-7.65%"
percent_change_from_52_week_high="-36.12%"
percent_change_from_52_week_low="+51.14%"
previous_close="70.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.16"
price_per_sales="22395.84"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="241166"
weeks_range_52="46.52 - 110.06"
